Spiro Rombotis
2016
In 2016, Spiro Rombotis earned a total compensation of $732K as President and Chief Executive Officer at Cyclacel Pharmaceuticals, a 25% decrease compared to previous year.
Compensation breakdown
| Bonus | $172,430 |
|---|---|
| Salary | $530,553 |
| Other | $28,980 |
| Total | $731,963 |
Rombotis received $530.6K in salary, accounting for 72% of the total pay in 2016.
Rombotis also received $172.4K in bonus and $29K in other compensation.
Rankings
In 2016, Spiro Rombotis' compensation ranked 9,690th out of 14,075 executives tracked by ExecPay. In other words, Rombotis earned more than 31.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,690 out of 14,075 | 31st |
Division Manufacturing | 3,753 out of 5,489 | 32nd |
Major group Chemicals And Allied Products | 1,306 out of 1,895 | 31st |
Industry group Drugs | 1,039 out of 1,538 | 32nd |
Industry Pharmaceutical Preparations | 816 out of 1,176 | 31st |
Source: SEC filing on April 12, 2017.
Rombotis' colleagues
We found two more compensation records of executives who worked with Spiro Rombotis at Cyclacel Pharmaceuticals in 2016.
News
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2023 pay slips 13% to $661K
May 7, 2024
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2022 pay falls 43% to $764K
April 28, 2023
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2021 pay slips 5% to $1.3M
April 26, 2022
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2020 pay jumps 39% to $1.4M
April 29, 2021
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2019 pay jumps 35% to $1M
May 12, 2020